解决喘生物学药物的治疗惯性:KOFU研究的教训
Tsutomu Tamada1, Hisatoshi Sugiura1
1Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
Respiratory investigation
|October 8, 2023
概括
在日本,由于治疗惯性,许多严重喘患者仍未得到充分治疗. 高昂的成本和不良的沟通是生物治疗的关键障碍,阻碍了有效的喘管理.
科学领域:
- 肺部病理学 肺部病理学
- 医疗保健管理的管理
- 患者倡导 患者倡导
背景情况:
- 尽管有可用的生物疗法,但严重的喘影响着很大一部分患者.
- 治疗惯性,源于患者,医生和系统因素,导致无法控制的严重喘.
- 日本现有的基于证据的指导方针和生物制剂尚未完全解决治疗缺口.
研究的目的:
- 为了确定阻碍在日本开始治疗严重喘的生物治疗的障碍.
- 调查严重喘管理中的治疗惯性潜在原因.
- 探索优化生物疗法采用的潜在解决方案.
主要方法:
- KOFU研究是一项大型横截面互联网调查,在日本进行.
- 该调查针对严重喘患者,以了解他们对治疗的看法.
- 数据分析的重点是确定生物治疗启动和延续的障碍.
主要成果:
- 高昂的医疗费用是考虑生物治疗的患者的主要障碍.
- 对喘严重程度的误解和对治疗强化需求的不充分认识是重大问题.
- 医生与患者之间的沟通不良,医生信任和复杂的保险流程也阻碍了生物接入.
结论:
- 解决财务负担和改善患者与医生的沟通对于克服生物治疗障碍至关重要.
- 对这些障碍的更好理解可以指导针对严重喘的个性化治疗建议.
- 需要简化保险流程和澄清生物资格标准的策略,以改善患者的治疗结果.
相关概念视频
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-IV: Nursing Management
3.1K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.1K
COPD: Management Using Bronchodilators and Corticosteroids
224
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
224
Asthma: Pathogenesis and Management
425
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
425
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
317
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
317
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K


